Business Insider

Amgen Announces Presentation Of Research Reinforcing The Long-Term Safety And Efficacy Of Repatha® (Evolocumab) In High-Risk Patients At AHA Scientific Sessions 2018

THOUSAND OAKS, Calif., Nov. 5, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of 10 scientific research abstracts, including the final report of the OSLER -1 study, ...
Business Insider

Amgen Presents Results Highlighting The Long-Term Safety And Efficacy Of Repatha® (Evolocumab) In The Longest Duration Study Of A PCSK9 Inhibitor To Date At AHA Scientific ...

In an effort to help more patients bring down the risk of heart attack and stroke, Amgen recently made Repatha available in the United States (U.S.) at a 60 percent reduced list price to address ...
Reuters

Amgen profit beats Street view, will not raise prices again in 2018

(Reuters) - Amgen Inc on Thursday reported a better-than-expected second quarter profit and raised its full-year earnings forecast, and its chief executive pledged not to raise drug prices again this ...
Reuters

Amgen Says Total Compensation For CEO Robert Bradway Was $19.6 Mln In 2019 Versus $18.6 Mln In 2018

* AMGEN - TOTAL COMPENSATION FOR CEO ROBERT BRADWAY WAS $19.6 MILLION IN 2019 VERSUS $18.6 MILLION IN 2018 Sign up here. * AMGEN - FOR 2019, RATIO OF ANNUAL TOTAL COMPENSATION OF CEO TO THAT OF MEDIAN ...
FiercePharma

Amgen vows to fight $7.1B tax bill tied to Puerto Rico manufacturing unit

When Amgen released first-quarter results on Wednesday, its sales and profit numbers were again overshadowed by a bombshell tax disclosure. Earlier this month, the company received a notice of ...